IL6 and type 2 diabetes mellitus: There is emerging evidence that chronic hyperglycemia via dysregulated production of tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and C-reactive protein (CRP), along with excess free radical production and oxidative stress, plays a critical role in the development of IR and T2DM (3).